Bio-Rad Laboratories, Inc. (BIO) stock surged +1.89%, trading at $360.54 on NYSE, up from the previous close of $353.86. The stock opened at $353.29, fluctuating between $351.63 and $360.93 in the recent session.
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Employees | 7700 |
Beta | 0.94 |
Sales or Revenue | $2.67B |
5Y Sales Change% | 0.191% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
Bio-Rad Laboratories, Inc. (NYSE: BIO) stock price is $360.54 in the last trading session. During the trading session, BIO stock reached the peak price of $360.93 while $351.63 was the lowest point it dropped to. The percentage change in BIO stock occurred in the recent session was 1.89% while the dollar amount for the price change in BIO stock was $6.68.
The NYSE listed BIO is part of Medical - Devices industry that operates in the broader Healthcare sector. Bio-Rad Laboratories, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Yong Chung
Vice President of Investor Relations
Dr. Andrew J. Last Ph.D.
Executive Vice President & Chief Operating Officer
Dr. Simon May
Executive Vice President & Pres of the Life Science Group
Mr. Norman D. Schwartz
Chairman, Chief Executive Officer & Pres
Mr. Michael Crowley
Executive Vice President of Global Commercial Operations
Mr. Ilan Daskal
Executive Vice President & Chief Financial Officer
Mr. Ajit Ramalingam
Senior Vice President & Chief Accounting Officer
Lee Boyd
Senior Vice President of Global Commercial Operations - Asia Pacific
Colleen Corey
Executive Vice President of Global HR
Mr. Timothy S. Ernst
Executive Vice President, Gen. Counsel & Sec.
Ms. Dara Grantham Wright
Executive Vice President & Pres of Clinical Diagnostics Group
Matthew Werner
Senior Vice President and Chief Compliance & Privacy Officer
BIO's closing price is 37.55% higher than its 52-week low of $262.12 where as its distance from 52-week high of $387.99 is -7.08%.
Number of BIO employees currently stands at 7,700.
Official Website of BIO is: https://www.bio-rad.com
BIO could be contacted at phone 510 724 7000 and can also be accessed through its website. BIO operates from 1000 Alfred Nobel Drive, Hercules, CA 94547, United States.
BIO stock volume for the day was 148.06K shares. The average number of BIO shares traded daily for last 3 months was 184.26K.
The market value of BIO currently stands at $10.07B with its latest stock price at $360.54 and 27.93M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com